Localization of 5-HT1A and 5-HT2A positive cells in the brainstems of control age-matched and Alzheimer individuals

Serotonin receptor 1A and 2A positive cells in postmortem brainstems were demonstrated via immunohistochemistry in eight control age-matched elderly individuals and eight Alzheimer patients. The 5-HT1A positive cells were found in substantia nigra, pontile nucleus, and vagal as well as dorsal raphe nucleus, while 5-HT2A receptor positive cells were found in motor, sensory and spinal trigeminal nuclei, pontile nucleus, substantia nigra, and nucleus solitarius. A comparison in density of positive cells per unit area was made between control age-matched and Alzheimer individuals. Statistically significant differences (p ≤ 0.01) in density were observed in 5-HT1A cells in pontile, dorsal raphe, and vagal nuclei between control age-matched and Alzheimer, and in 5-HT2A positive cells in the sensory trigeminal nucleus, between control and Alzheimer. This de novo study indicated the presence of 5-HT1A and 5-HT2A receptor positive cells in the above nuclei of human brainstem and revealed differences in density between control age-matched and Alzheimer, indicating possible functional derangements in Alzheimer patients in these areas. In addition, colocalization studies indicated that 5-HT1A receptors were in cholinergic cells and gamma-aminobutyric acid positive fibers were linked to 5-HT2A receptor positive cells. It is hoped that understanding these two important 5-HT receptors and their localization might lead to advances in future therapeutic development.

[1]  L. Murri,et al.  Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease. , 2003, Genetic testing.

[2]  Joseph P. Huston,et al.  Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors , 2007, Progress in Neurobiology.

[3]  R. Schreiber,et al.  The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test , 1998, Psychopharmacology.

[4]  K. Pang,et al.  Immunohistochemical and ultrastructural studies of the various nuclei of the trigeminal complex in the human newborn , 1991, Neuroscience.

[5]  A. Wesołowska.  In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors. , 2002, Polish journal of pharmacology.

[6]  D. Yew,et al.  Habenulo-interpeduncular descending pathways and their relationship to enkephalin- and somatostatin-immunoreactive neurons in the interpeduncular nucleus of human fetuses , 1993, Neuroscience.

[7]  M. Wong-Riley,et al.  Postnatal changes in the expressions of serotonin 1A, 1B, and 2A receptors in ten brain stem nuclei of the rat: implication for a sensitive period , 2010, Neuroscience.

[8]  S. Webb,et al.  Neurotransmitters, peptides, and neural cell adhesion molecules in the cortices of normal elderly humans and alzheimer patients: a comparison , 1999, Experimental Gerontology.

[9]  W. Chan,et al.  Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and alzheimer patients , 1997, Journal of Molecular Neuroscience.

[10]  H. Wikström,et al.  Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635 , 1997, Brain Research.

[11]  M. Delgado,et al.  Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors. , 2005, European journal of pharmacology.

[12]  O. Mutlu,et al.  Involvement of serotonin receptor subtypes in the antidepressant-like effect of trim in the rat forced swimming test , 2010, Pharmacology Biochemistry and Behavior.

[13]  P. Hrdina.  Basic Neurochemistry: Molecular, Cellular and Medical Aspects. , 1996 .

[14]  E. Nalivaiko,et al.  Activation of 5-HT1A receptors in the medullary raphe reduces cardiovascular changes elicited by acute psychological and inflammatory stresses in rabbits. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[15]  D. E. Nichols,et al.  Serotonin receptors. , 2008, Chemical reviews.

[16]  J. Horáček,et al.  Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics , 2008, Advances in therapy.

[17]  H. Furue,et al.  Responses to 5-HT in morphologically identified neurons in the rat substantia gelatinosa in vitro , 2009, Neuroscience.

[18]  Paul J. Harrison,et al.  The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain , 1995, Brain Research.

[19]  Laguzzi Raul.  Serotonin2 Receptors in the Nucleus Tractus Solitarius: Characterization and Role in the Baroreceptor Reflex Arc , 2003, Cellular and Molecular Neurobiology.

[20]  D. Yew,et al.  Distribution of Neuropeptide Y-Immunoreactive Neurons in the Human Brainstem, Cerebellum, and Cortex During Development , 2004, Cellular and Molecular Neurobiology.

[21]  L. Meyer,et al.  Zacopride and 8-OH-DPAT reverse opioid-induced respiratory depression and hypoxia but not catatonic immobilization in goats. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[22]  E. Salmon.  A review of the literature on neuroimaging of serotoninergic function in Alzheimer’s disease and related disorders , 2007, Journal of Neural Transmission.

[23]  S. Webb,et al.  Neurotransmitters and peptides in the developing human facial nucleus , 1996, Neuroscience Letters.

[24]  C. Shi,et al.  Development of the human insular cortex: differentiation, proliferation, cell death, and appearance of 5HT-2A receptors , 2008, Histochemistry and Cell Biology.

[25]  B. Roth,et al.  Molecular biology of serotonin receptors structure and function at the molecular level. , 2002, Current topics in medicinal chemistry.

[26]  Paul Chen,et al.  Activation of 5-HT2A/C Receptors Counteracts 5-HT1A Regulation of N-Methyl-D-aspartate Receptor Channels in Pyramidal Neurons of Prefrontal Cortex , 2008, Journal of Biological Chemistry.

[27]  J. Leiter,et al.  Baroreceptor‐mediated inhibition of respiration after peripheral and central administration of a 5‐HT1A receptor agonist in neonatal piglets , 2007, Experimental physiology.

[28]  P. Molinoff,et al.  Basic Neurochemistry: Molecular, Cellular and Medical Aspects , 1989 .

[29]  R. Shelton,et al.  Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A , 2009, Neuroscience.

[30]  W. Chan,et al.  Neurotransmitters and Neuropeptides in the Developing Human Central Nervous System , 1999, Neurosignals.

[31]  D. Yew,et al.  Nitric oxide synthase neurons in different areas of normal aged and Alzheimer's brains , 1999, Neuroscience.

[32]  M. Panicker,et al.  Serotonin 2A (5-HT2A) Receptor Function: Ligand-Dependent Mechanisms and Pathways , 2007 .

[33]  N. Lazarov.  Comparative analysis of the chemical neuroanatomy of the mammalian trigeminal ganglion and mesencephalic trigeminal nucleus , 2002, Progress in Neurobiology.

[34]  W. Chan,et al.  Development of catecholaminergic neurons in the human medulla oblongata. , 2003, Life sciences.

[35]  Ming Fan,et al.  The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain , 2007, Neurochemistry International.

[36]  S. Glatt,et al.  Serotonergic system genes in psychosis of Alzheimer dementia: meta-analysis. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[37]  N. Coimbra,et al.  Serotonergic neurotransmission in the dorsal raphe nucleus recruits in situ 5-HT2A/2C receptors to modulate the post-ictal antinociception , 2008, Experimental Neurology.

[38]  D. Popa,et al.  Contribution of 5-HT2 Receptor Subtypes to Sleep–Wakefulness and Respiratory Control, and Functional Adaptations in Knock-Out Mice Lacking 5-HT2A Receptors , 2005, The Journal of Neuroscience.

[39]  Zhen Yan.  Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex , 2002, Molecular Neurobiology.

[40]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[41]  J. Groswasser,et al.  Serotonergic receptors in the midbrain correlated with physiological data on sleep apnea in SIDS victims. , 2003, Early human development.

[42]  Christer Halldin,et al.  A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain , 2007, Psychopharmacology.

[43]  W. Z. Chen,et al.  Development and localization of enkephalin and substance P in the nucleus of tractus solitarius in the medulla oblongata of human fetuses , 1990, Neuroscience.

[44]  N. Okado,et al.  Alteration of serotonergic receptors in the brain stems of human patients with respiratory disorders. , 2002, Neuropediatrics.

[45]  P R Saxena,et al.  Serotonin receptors: subtypes, functional responses and therapeutic relevance. , 1995, Pharmacology & therapeutics.

[46]  A. Chattopadhyay.  Serotonin Receptors in Neurobiology , 2007 .

[47]  W. Chan,et al.  Early appearance of acetylcholinergic, serotoninergic, and peptidergic neurons and fibers in the developing human central nervous system , 1999, Microscopy research and technique.

[48]  V. Arango,et al.  Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice , 2003, Biological Psychiatry.

[49]  G. Kennett,et al.  Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. , 1987, European journal of pharmacology.

[50]  V. Arango,et al.  Serotonin brain circuits involved in major depression and suicide. , 2002, Progress in brain research.

[51]  D. Yew,et al.  Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients , 2006, BMC Neuroscience.

[52]  I. Aneas,et al.  Social isolation and expression of serotonergic neurotransmission‐related genes in several brain areas of male mice , 2007, Genes, brain, and behavior.

[53]  D. Jordan.  Vagal control of the heart: central serotonergic (5‐HT) mechanisms , 2005, Experimental physiology.

[54]  B. Costall,et al.  Biochemical models for cognition enhancers. , 1990, Pharmacopsychiatry.